Urgent Field Safety Notice for Quantum Blue Anti-Infliximab by Bühlmann Laboratories AG
2022.01.24
Product group In-vitro diagnostics - immunological products
Reference 00697/22
For further information as well as details concerning the device please see the enclosed Advisory Notice of the manufacturer.